After filtering genes by RPKM and fold change, we found that gene expression levels of GBP5 were increased by 9.10-fold and 6.59-fold in stages I (T1) and stages IV (T2) tumor tissues, respectively, compared with those in CTAN tissues (N1 and N2) (Figure 1A). This evidence concerns the gene GBP5 and neoplasm.